GKOS on NYSE

GLAUKOS Corp

American surgical and medical instruments and apparatus company. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with AtriCure (United States), Bioventus Inc. or CryoLife, or pick any stock.

  • TickerGKOS on NYSE2
  • IndustrySurgical & Medical Instruments & Apparatus2
  • HeadquartersSan Clemente, United States2
  • Incorporated inDE3
  • Business address1 Glaukos Way, Aliso Viejo, Ca 926563
  • Filer categoryLarge accelerated filer3
  • Legal formCorporation2
  • LEI5299004JA1LHE21M6T142
  • StatusActive2
  • LEI statusIssued and current2
  • Registered addressc/o DELAWARE CORPORATION ORGANIZERS, INC., 1201 NORTH MARKET ST, FL 18, P.O. BOX 1347, 19801 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 28959682

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

55.7%Gross margin4
-39.3%Operating margin4
-37.0%Net margin4
32.3%Revenue growth, 20254
-28.6%Return on equity4
-$22.5MFree cash flow4

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Glaucoma brought in 83% of the revenue GLAUKOS Corp broke down this way in fiscal 2025.

  1. Glaucoma$421.1M483%up 39% from 2024
  2. Corneal Health$86.4M417%up 8% from 2024
Products and services by year
Products and services202320242025
Glaucoma$237.0M$303.3M$421.1M
Corneal Health$77.7M$80.2M$86.4M

Regions

United States brought in 74% of the revenue GLAUKOS Corp broke down this way in fiscal 2025.

  1. United States$375.0M474%up 39% from 2024
  2. Outside the United States$132.4M426%up 17% from 2024
Regions by year
Regions202320242025
United States$219.4M$270.1M$375.0M
Outside the United States$95.3M$113.4M$132.4M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue22¢$111.8M
  • Selling, general and admin65¢$331.7M
  • Other costs12¢$58.5M
  • Income tax1¢$5.4M

Out of $507.4M in revenue.4 The company lost money this year.

Financial statements

Revenue56784$507.4M in 2025+114% since 2019
0$200.0M$400.0M$600.0M2019: $237.0M$237.0M20192020: $225.0M$225.0M2020−5%2021: $294.0M$294.0M2021+31%2022: $282.9M$282.9M2022−4%2023: $314.7M$314.7M2023+11%2024: $383.5M$383.5M2024+22%2025: $507.4M$507.4M2025+32%
Gross profit56784$282.8M in 2025+43% since 2019
0$100.0M$200.0M$300.0M2019: $198.4M$198.4M20192020: $133.2M$133.2M2020−33%2021: $227.4M$227.4M2021+71%2022: $213.9M$213.9M2022−6%2023: $239.1M$239.1M2023+12%2024: $289.5M$289.5M2024+21%2025: $282.8M$282.8M2025−2%
Operating income56784-$199.6M in 2025+297% since 2019
-$200.0M-$150.0M-$100.0M-$50.0M02019: -$50.3M-$50.3M20192020: -$123.6M-$123.6M2020+146%2021: -$32.9M-$32.9M2021−73%2022: -$82.3M-$82.3M2022+150%2023: -$128.7M-$128.7M2023+56%2024: -$122.4M-$122.4M2024−5%2025: -$199.6M-$199.6M2025+63%
Net income56784-$187.7M in 2025
-$200.0M-$100.0M0$100.0M2019: $15.4M$15.4M20192020: -$120.3M-$120.3M20202021: -$49.6M-$49.6M2021−59%2022: -$99.2M-$99.2M2022+100%2023: -$134.7M-$134.7M2023+36%2024: -$146.4M-$146.4M2024+9%2025: -$187.7M-$187.7M2025+28%

Every line of the income statement as filed: the last 3 fiscal years, latest first.4

Period ending2025-12-312024-12-312023-12-31
Net sales$507.4M$383.5M$314.7M
Cost of sales$111.8M$94.0M$75.6M
Impairment of intangible asset$112.9M
Gross profit$282.8M$289.5M$239.1M
Selling, general and administrative$331.7M$261.2M$224.1M
Research and development$150.6M$136.4M$138.8M
Acquired in-process research and development$14.2M$5.0M
Total operating expenses$482.4M$411.8M$367.8M
Loss from operations-$199.6M-$122.4M-$128.7M
Interest income$10.7M$11.1M$9.2M
Interest expense-$4.6M-$10.0M-$13.6M
Charges associated with convertible senior notes-$18.0M
Other income (expense), net$479.0K-$6.3M-$558.0K
Total non-operating income (expense)$6.6M-$23.2M-$5.0M
Loss before taxes-$193.0M-$145.6M-$133.7M
Income tax (benefit) provision-$5.4M$771.0K$934.0K
Net loss-$187.7M-$146.4M-$134.7M
Basic net loss per share (in dollar per share)-$3.28-$2.77-$2.78
Diluted net loss per share (in dollar per share)-$3.28-$2.77-$2.78
Weighted average shares outstanding used to compute basic net loss per share57.2M shares52.8M shares48.4M shares
Weighted average shares outstanding used to compute diluted net loss per share57.2M shares52.8M shares48.4M shares

Compare GLAUKOS Corp with another company

Leadership

Who has led GLAUKOS Corp, and when. Pick a name to see everywhere that person has worked.

President

  1. Joseph E. Gilliam2022–now

Chief financial officer

  1. Richard L. Harrison2015–2017
  2. Joseph E. Gilliam2017–2022
  3. Alex R. Thurman2022–now

Chief operating officer

  1. Chris M. Calcaterra2018–2022
  2. Joseph E. Gilliam2022–now
20202025
Board members and other officers (14)

Timeline

  1. Jul 14, 1998Founded GLAUKOS Corp is founded2

Filings

573 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 60 major events, 326 insider forms, 31 large holders, 136 other. The latest 20:

  1. Oct 7, 20264 EDGAR
  2. Oct 5, 2026144 EDGAR
  3. Sep 28, 20264 EDGAR
  4. Sep 25, 2026144 EDGAR
  5. Sep 18, 20264 EDGAR
  6. Sep 16, 2026144 EDGAR
  7. Sep 1, 20264 EDGAR
  8. Aug 28, 2026144 EDGAR
  9. Aug 20, 20264 EDGAR
  10. Aug 19, 2026144 EDGAR
  11. Aug 13, 20264 EDGAR
  12. Aug 11, 2026144 EDGAR
  13. Aug 11, 20264 EDGAR
  14. Aug 7, 2026144 EDGAR
  15. Aug 3, 20264 EDGAR
  16. Aug 3, 20268-K EDGAR
  17. Jul 31, 2026144 EDGAR
  18. Jul 29, 202610-Q EDGAR
  19. Jul 29, 20268-K EDGAR
  20. Jul 21, 20264 EDGAR

The 573 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

112 open-market trades by officers, directors and large owners since October 2021: 0 buys and 112 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 25, 2026Navratil TomasCHIEF DEVELOPMENT OFFICERSale1,615$154.28$249.2KForm 4
Sep 16, 2026Navratil TomasCHIEF DEVELOPMENT OFFICERSale1,457$166.92$243.2KForm 4
Aug 28, 2026Navratil TomasCHIEF DEVELOPMENT OFFICERSale13,744$180.67$2.5MForm 4
Aug 19, 2026Kliman Gilbert HDirectorSale2,500$190.00$475.0KForm 4
Aug 11, 2026Gilliam Joseph EPRESIDENT & COOSale60,000$179.74$10.8MForm 4
Aug 7, 2026Thurman Alex R.SVP & CHIEF FINANCIAL OFFICERSale20,000$180.13$3.6MForm 4
Jul 31, 2026WEN LEANADirectorSale525$167.63$88.0KForm 4
Jul 16, 2026Thurman Alex R.SVP & CHIEF FINANCIAL OFFICERSale10,000$160.00$1.6MForm 4
Jul 9, 2026Thurman Alex R.SVP & CHIEF FINANCIAL OFFICERSale10,000$155.00$1.6MForm 4
Jul 6, 2026Thurman Alex R.SVP & CHIEF FINANCIAL OFFICERSale10,000$150.00$1.5MForm 4
Jul 1, 2026Navratil TomasCHIEF DEVELOPMENT OFFICERSale716$139.06$99.6KForm 4
Jun 16, 2026Navratil TomasCHIEF DEVELOPMENT OFFICERSale1,537$130.68$200.9KForm 4
May 14, 2026Kliman Gilbert HDirectorSale5,000$140.76$703.8KForm 4
May 11, 2026Kliman Gilbert HDirectorSale5,000$135.00$675.0KForm 4
May 1, 2026WEN LEANADirectorSale1,700$143.35$243.7KForm 4
May 1, 2026Gilliam Joseph EPRESIDENT & COOSale19,573$143.54$2.8MForm 4
Apr 30, 2026Thurman Alex R.SVP & CHIEF FINANCIAL OFFICERSale10,000$140.00$1.4MForm 4
Apr 10, 2026Navratil TomasCHIEF DEVELOPMENT OFFICERSale2,093$117.62$246.2KForm 4
Mar 25, 2026Thurman Alex R.SVP & CHIEF FINANCIAL OFFICERSale2,511$106.46$267.3KForm 4
Mar 24, 2026Thurman Alex R.SVP & CHIEF FINANCIAL OFFICERSale1,521$105.24$160.1KForm 4

All 112 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.9,540,056$1.3B0.0%+450,027
Jupiter Topco LLC4,862,894$679.6M0.3%New
Vanguard Portfolio Management LLC3,321,839$464.3M0.0%+113,476
Primecap Management Co/ca/3,040,705$425.0M0.3%−329,923
Vanguard Capital Management LLC2,551,132$356.5M0.0%+42,361
State Street Corp2,315,568$323.7M0.0%+132,951
Millennium Management LLC1,581,016$221.0M0.2%+407,320
Holocene Advisors, LP1,514,931$211.7M0.5%+131,216
Geode Capital Management, LLC1,463,448$204.6M0.0%+106,995
Citadel Advisors LLC1,390,017$194.3M0.1%−56,909
Ameriprise Financial Inc1,315,057$183.8M0.0%−295,717
Capital World Investors1,015,943$142.0M0.0%+26,883
Alliancebernstein L.P.1,254,703$135.1M0.0%−142,853
Goldman Sachs Group Inc897,021$125.4M0.0%−477,937
Charles Schwab Investment Management Inc752,642$105.2M0.0%+38,253
Invesco Ltd.706,877$98.8M0.0%−207,311
William Blair Investment Management, LLC661,675$92.5M0.3%−412,144
Driehaus Capital Management LLC650,571$90.9M0.5%+162,659
Nomura Asset Management International Inc.647,428$90.5M0.1%+35,365
Northern Trust Corp612,496$85.6M0.0%+36,287
Braidwell LP591,927$82.7M3.2%−171,578
Morgan Stanley589,793$82.4M0.0%−89,032
Bank Of America Corp /de/587,327$82.1M0.0%−70,105
UBS Group AG578,271$80.8M0.0%+191,871
Fuller & Thaler Asset Management, Inc.529,922$74.1M0.2%New

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41